Atlas Trials

A Study to Learn About the Effects of Multiple Doses of Sisunatovir on People With Respiratory Syncytial Virus (RSV) Infection

Clinical trial NCT03258502 · COMPLETED

Trial details

NCT number
NCT03258502
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Respiratory Syncytial Virus Infections
Start date
2017-07-19
Primary completion
2017-10-31
Enrollment
66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.